In this Clinical Care Options (CCO) expert commentary, Sagar Lonial, MD, provides his thoughts on the key studies in myeloma presented at ASH 2019
From Clinical Care Options (CCO), read expert answers to key questions from community practitioners on optimizing CAR T-cell therapy
Eunice S. Wang, MD, provides expert insights on a novel chemotherapy/immunotherapy combination for treating ALL in this commentary from Clinical Care Options (CCO)
Ian W. Flinn, MD, PhD, answers frequently asked questions on use of BTK inhibitors in patients with hematologic malignancies in this CCO commentary
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.